Published in Proc Natl Acad Sci U S A on May 03, 2005
The controlled generation of functional basal forebrain cholinergic neurons from human embryonic stem cells. Stem Cells (2011) 1.32
BMP9 signaling in stem cell differentiation and osteogenesis. Am J Stem Cells (2013) 1.17
Autocrine bone morphogenetic protein-9 signals through activin receptor-like kinase-2/Smad1/Smad4 to promote ovarian cancer cell proliferation. Cancer Res (2009) 1.14
Molecular networks involved in mouse cerebral corticogenesis and spatio-temporal regulation of Sox4 and Sox11 novel antisense transcripts revealed by transcriptome profiling. Genome Biol (2009) 1.14
The dynamic role of bone morphogenetic proteins in neural stem cell fate and maturation. Dev Neurobiol (2012) 1.10
TGFbeta signaling in Tribolium: vertebrate-like components in a beetle. Dev Genes Evol (2008) 1.00
Sizn1 is a novel protein that functions as a transcriptional coactivator of bone morphogenic protein signaling. Mol Cell Biol (2007) 0.94
BMP signaling in mesenchymal stem cell differentiation and bone formation. J Biomed Sci Eng (2013) 0.89
BMP9 (bone morphogenetic protein 9) induces NGF as an autocrine/paracrine cholinergic trophic factor in developing basal forebrain neurons. J Neurosci (2010) 0.87
BMP9 ameliorates amyloidosis and the cholinergic defect in a mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A (2013) 0.86
IGF2 ameliorates amyloidosis, increases cholinergic marker expression and raises BMP9 and neurotrophin levels in the hippocampus of the APPswePS1dE9 Alzheimer's disease model mice. PLoS One (2014) 0.85
Organ-specific adaptive signaling pathway activation in metastatic breast cancer cells. Oncotarget (2015) 0.83
Axotomy-induced neurotrophic withdrawal causes the loss of phenotypic differentiation and downregulation of NGF signalling, but not death of septal cholinergic neurons. Mol Neurodegener (2010) 0.83
BMP9 protects septal neurons from axotomy-evoked loss of cholinergic phenotype. PLoS One (2011) 0.83
Potential roles of bone morphogenetic protein (BMP)-9 in human liver diseases. Int J Mol Sci (2014) 0.82
Transcriptional responses of cultured rat sympathetic neurons during BMP-7-induced dendritic growth. PLoS One (2011) 0.80
Roles of bone morphogenetic protein signaling in osteosarcoma. Int Orthop (2014) 0.78
Common pitfalls of stem cell differentiation: a guide to improving protocols for neurodegenerative disease models and research. Cell Mol Life Sci (2016) 0.78
Differential modulation of nerve growth factor receptor (p75) and cholinergic gene expression in purified p75-expressing and non-expressing basal forebrain neurons by BMP9. Brain Res (2008) 0.78
Intranasal BMP9 Ameliorates Alzheimer Disease-Like Pathology and Cognitive Deficits in APP/PS1 Transgenic Mice. Front Mol Neurosci (2017) 0.75
Crosstalk among electrical activity, trophic factors and morphogenetic proteins in the regulation of neurotransmitter phenotype specification. J Chem Neuroanat (2015) 0.75
The promise of stem cells in the therapy of Alzheimer's disease. Transl Neurodegener (2015) 0.75
Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts. Nature (1999) 6.50
Twenty proteins containing a C-terminal SOCS box form five structural classes. Proc Natl Acad Sci U S A (1998) 4.38
Acute stress facilitates long-lasting changes in cholinergic gene expression. Nature (1998) 3.46
OAZ uses distinct DNA- and protein-binding zinc fingers in separate BMP-Smad and Olf signaling pathways. Cell (2000) 3.12
Bone morphogenetic proteins (BMPs) as regulators of dorsal forebrain development. Development (1997) 2.93
Specification of catecholaminergic and serotonergic neurons. Nat Rev Neurosci (2002) 2.38
Regulation of motor neuron pool sorting by differential expression of type II cadherins. Cell (2002) 2.32
On neurodegenerative diseases, models, and treatment strategies: lessons learned and lessons forgotten a generation following the cholinergic hypothesis. Exp Neurol (2000) 2.28
Embryonic lethality of molecular chaperone hsp47 knockout mice is associated with defects in collagen biosynthesis. J Cell Biol (2000) 2.24
Pigment epithelium-derived factor: neurotrophic activity and identification as a member of the serine protease inhibitor gene family. Proc Natl Acad Sci U S A (1993) 2.15
BMP2-mediated alteration in the developmental pathway of fetal mouse brain cells from neurogenesis to astrocytogenesis. Proc Natl Acad Sci U S A (2001) 2.01
Direct binding of Smad1 and Smad4 to two distinct motifs mediates bone morphogenetic protein-specific transcriptional activation of Id1 gene. J Biol Chem (2001) 1.99
Sequential actions of BMP receptors control neural precursor cell production and fate. Genes Dev (2001) 1.84
The signalling molecule BMP4 mediates apoptosis in the rhombencephalic neural crest. Nature (1994) 1.77
Induction and maintenance of the neuronal cholinergic phenotype in the central nervous system by BMP-9. Science (2000) 1.68
Expression and genetic interaction of transcription factors GATA-2 and GATA-3 during development of the mouse central nervous system. Dev Biol (1999) 1.64
Neural cell recognition molecule L1: from cell biology to human hereditary brain malformations. Curr Opin Neurobiol (1998) 1.51
Structural conservation of Notch receptors and ligands. Semin Cell Dev Biol (1998) 1.46
Essential role of Gata transcription factors in sympathetic neuron development. Development (2004) 1.45
The role of BMP-4 and GATA-2 in the induction and differentiation of hematopoietic mesoderm in Xenopus laevis. Blood (1996) 1.37
Ninjurin2, a novel homophilic adhesion molecule, is expressed in mature sensory and enteric neurons and promotes neurite outgrowth. J Neurosci (2000) 1.35
The 14-3-3s. Genome Biol (2002) 1.28
Suppressor of cytokine signaling 2 regulates neuronal differentiation by inhibiting growth hormone signaling. Nat Neurosci (2002) 1.25
Identification of the neuroprotective molecular region of pigment epithelium-derived factor and its binding sites on motor neurons. J Neurosci (2002) 1.23
SC1/hevin. An extracellular calcium-modulated protein that binds collagen I. J Biol Chem (2003) 1.09
Bone morphogenetic protein-6 reduces ischemia-induced brain damage in rats. Stroke (2001) 1.08
The roles of cadherins and nectins in interneuronal synapse formation. Curr Opin Neurobiol (2003) 1.06
Mechanisms underlying cytokine-mediated cell-fate regulation in the nervous system. Mol Neurobiol (2002) 1.05
Localization and development of nerve growth factor-sensitive rat basal forebrain neurons and their afferent projections to hippocampus and neocortex. J Neurosci (1989) 1.01
Nerve growth factor receptor is associated with cholinergic neurons of the basal forebrain but not the pontomesencephalon. Neuroscience (1989) 0.98
Bone morphogenetic proteins are involved in fetal kidney tissue transplantation-induced neuroprotection in stroke rats. Neuropharmacology (2002) 0.97
Opposite effects of FGF and BMP-4 on embryonic blood formation: roles of PV.1 and GATA-2. Dev Biol (1999) 0.95
Domains of cellular retinoic acid-binding protein I (CRABP I) expression in the hindbrain and neural crest of the mouse embryo. Mech Dev (1992) 0.92
Mesenchymal/epithelial regulation of retinoic acid signaling in the olfactory placode. Dev Biol (2003) 0.91
Bone morphogenetic proteins and bone morphogenetic protein gene therapy in neurological surgery: a review. Neurosurgery (2000) 0.88
SC1, a brain extracellular matrix glycoprotein related to SPARC and follistatin, is expressed by rat cerebellar astrocytes following injury and during development. Brain Res (1996) 0.87
Bone morphogenetic protein-4-induced activation of Xretpos is mediated by Smads and Olf-1/EBF associated zinc finger (OAZ). Nucleic Acids Res (2002) 0.87
RLP, a novel Ras-like protein, is an immediate-early transforming growth factor-beta (TGF-beta) target gene that negatively regulates transcriptional activity induced by TGF-beta. Biochem J (2004) 0.87
Expression of bone morphogenetic protein-6 and transforming growth factor-beta1 in the rat brain after a mild and reversible ischemic damage. Brain Res (2001) 0.85
Bone morphogenetic proteins (BMP6 and BMP7) enhance the protective effect of neurotrophins on cultured septal cholinergic neurons during hypoglycemia. J Neurochem (2001) 0.85
Depolarization differentially regulates the effects of bone morphogenetic protein (BMP)-2, BMP-6, and activin A on sympathetic neuronal phenotype. J Neurochem (1994) 0.84
Coexistence of choline acetyltransferase and nerve growth factor receptors in the rat basal forebrain. Neurosci Lett (1988) 0.84
Complementary expression and regulation of cadherins 6 and 11 during specific steps of motoneuron differentiation. Mol Cell Neurosci (2002) 0.83
Differential regulation of distinct phenotypic features of serotonergic neurons by bone morphogenetic proteins. Eur J Neurosci (1999) 0.83
Bone morphogenetic proteins and neurotrophins provide complementary protection of septal cholinergic function during phosphatase inhibitor-induced stress. J Neurochem (2004) 0.83
Treatment of cerebellar granule cell neurons with the neurotrophic factor pigment epithelium-derived factor in vitro enhances expression of other neurotrophic factors as well as cytokines and chemokines. J Neurosci Res (2004) 0.81
Differential expression of sympathoadrenal lineage-determining genes and phenotypic markers in cultured primary neural crest cells. In Vitro Cell Dev Biol Anim (2001) 0.80
Spatio-temporal distribution of cellular retinol-binding protein gene transcripts (CRBPI and CRBPII) in the developing and adult zebrafish (Danio rerio). Eur J Biochem (2004) 0.79
Expression of serine/threonine kinase receptors in traumatic brain injury. Neuroreport (1997) 0.79
Bone morphogenetic proteins (BMP-2 and BMP-3) induce the late phase expression of the proto-oncogene c-fos in murine osteoblastic MC3T3-E1 cells. FEBS Lett (1992) 0.79
Leukaemia inhibitory factor prevents loss of p75-nerve growth factor receptor immunoreactivity in medial septal neurons following fimbria-fornix lesions. Neuroscience (1999) 0.78
Gene expression in human embryonic stem cell lines: unique molecular signature. Blood (2003) 3.73
Loss of the forkhead transcription factor FoxM1 causes centrosome amplification and mitotic catastrophe. Cancer Res (2005) 3.23
MPSS profiling of human embryonic stem cells. BMC Dev Biol (2004) 2.17
Acetylcholine is synthesized by and acts as an autocrine growth factor for small cell lung carcinoma. Cancer Res (2003) 1.61
Inhibition of dynamin-dependent endocytosis increases shedding of the amyloid precursor protein ectodomain and reduces generation of amyloid beta protein. BMC Cell Biol (2005) 1.53
Gestational choline deficiency causes global and Igf2 gene DNA hypermethylation by up-regulation of Dnmt1 expression. J Biol Chem (2007) 1.43
Oligodendrocyte progenitor cells derived from human embryonic stem cells express neurotrophic factors. Stem Cells Dev (2006) 1.35
Developmental periods of choline sensitivity provide an ontogenetic mechanism for regulating memory capacity and age-related dementia. Front Integr Neurosci (2008) 1.26
Regulation of gene expression in mouse macrophages stimulated with bacterial CpG-DNA and lipopolysaccharide. J Leukoc Biol (2002) 1.25
Gestational choline supply regulates methylation of histone H3, expression of histone methyltransferases G9a (Kmt1c) and Suv39h1 (Kmt1a), and DNA methylation of their genes in rat fetal liver and brain. J Biol Chem (2008) 1.21
Prenatal choline supplementation advances hippocampal development and enhances MAPK and CREB activation. FASEB J (2004) 1.20
Axin pathway activity regulates in vivo pY654-β-catenin accumulation and pulmonary fibrosis. J Biol Chem (2011) 1.17
Prenatal choline availability modulates hippocampal neurogenesis and neurogenic responses to enriching experiences in adult female rats. Eur J Neurosci (2007) 1.16
Monitoring early differentiation events in human embryonic stem cells by massively parallel signature sequencing and expressed sequence tag scan. Stem Cells Dev (2004) 1.15
Choline transporter 1 maintains cholinergic function in choline acetyltransferase haploinsufficiency. J Neurosci (2004) 1.14
Global profiling of phosphopeptides by titania affinity enrichment. J Proteome Res (2007) 1.11
Comment on "Multiple repressive mechanisms in the hippocampus during memory formation". Science (2016) 1.07
Delineation of a cellular hierarchy in lung cancer reveals an oncofetal antigen expressed on tumor-initiating cells. Cancer Res (2011) 1.07
Age-related declines in exploratory behavior and markers of hippocampal plasticity are attenuated by prenatal choline supplementation in rats. Brain Res (2008) 1.03
Efficacy and pharmacodynamic effects of bosutinib (SKI-606), a Src/Abl inhibitor, in freshly generated human pancreas cancer xenografts. Mol Cancer Ther (2009) 1.01
Bacterial LPS and CpG DNA differentially induce gene expression profiles in mouse macrophages. J Endotoxin Res (2003) 0.99
Prenatal choline supplementation attenuates neuropathological response to status epilepticus in the adult rat hippocampus. Neurobiol Dis (2008) 0.99
M1 and M3 muscarinic receptors control physiological processing of cellular prion by modulating ADAM17 phosphorylation and activity. J Neurosci (2007) 0.98
Prenatal choline supplementation in rats increases the expression of IGF2 and its receptor IGF2R and enhances IGF2-induced acetylcholine release in hippocampus and frontal cortex. Brain Res (2008) 0.97
Zebrafish as a genetic model in biological and behavioral gerontology: where development meets aging in vertebrates--a mini-review. Gerontology (2009) 0.96
Spatial memory and hippocampal plasticity are differentially sensitive to the availability of choline in adulthood as a function of choline supply in utero. Brain Res (2008) 0.95
Prenatal choline availability modulates hippocampal and cerebral cortical gene expression. FASEB J (2007) 0.94
Purification and culture of nerve growth factor receptor (p75)-expressing basal forebrain cholinergic neurons. Nat Protoc (2008) 0.93
The extracellular regulated kinase-1 (ERK1) controls regulated alpha-secretase-mediated processing, promoter transactivation, and mRNA levels of the cellular prion protein. J Biol Chem (2011) 0.93
Development of a focused microarray to assess human embryonic stem cell differentiation. Stem Cells Dev (2005) 0.91
Developmental pattern of expression of BMP receptors and Smads and activation of Smad1 and Smad5 by BMP9 in mouse basal forebrain. Brain Res (2006) 0.90
Effects of postnatal dietary choline supplementation on motor regional brain volume and growth factor expression in a mouse model of Rett syndrome. Brain Res (2008) 0.89
Choline nutrition programs brain development via DNA and histone methylation. Cent Nerv Syst Agents Med Chem (2012) 0.89
IkappaBalpha kinase inhibitor IKI-1 conferred tumor necrosis factor alpha sensitivity to pancreatic cancer cells and a xenograft tumor model. Cancer Res (2008) 0.88
BMP9 (bone morphogenetic protein 9) induces NGF as an autocrine/paracrine cholinergic trophic factor in developing basal forebrain neurons. J Neurosci (2010) 0.87
Prenatal choline supplementation protects against postnatal neurotoxicity. J Neurosci (2002) 0.86
BMP9 ameliorates amyloidosis and the cholinergic defect in a mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A (2013) 0.86
Upregulation of acetylcholine synthesis by bone morphogenetic protein 9 in a murine septal cell line. J Physiol Paris (2001) 0.84
Perinatal choline deficiency produces abnormal sensory inhibition in Sprague-Dawley rats. Brain Res (2008) 0.84
Isoform-specific contribution of protein kinase C to prion processing. Mol Cell Neurosci (2008) 0.84
Differential regulation of the high affinity choline transporter and the cholinergic locus by cAMP signaling pathways. Brain Res (2007) 0.83
Expression of high affinity choline transporter during mouse development in vivo and its upregulation by NGF and BMP-4 in vitro. Brain Res Dev Brain Res (2005) 0.83
BMP9 protects septal neurons from axotomy-evoked loss of cholinergic phenotype. PLoS One (2011) 0.83
Water maze experience and prenatal choline supplementation differentially promote long-term hippocampal recovery from seizures in adulthood. Hippocampus (2010) 0.83
Design and synthesis of novel diaminoquinazolines with in vivo efficacy for beta-catenin/T-cell transcriptional factor 4 pathway inhibition. J Med Chem (2010) 0.83
Regulation of cholinergic gene expression by nerve growth factor depends on the phosphatidylinositol-3'-kinase pathway. J Neurochem (2005) 0.83
Prenatal choline deficiency increases choline transporter expression in the septum and hippocampus during postnatal development and in adulthood in rats. Brain Res (2007) 0.83
Nerve growth factor regulates the expression of the cholinergic locus and the high-affinity choline transporter via the Akt/PKB signaling pathway. J Neurochem (2008) 0.80
Raising gestational choline intake alters gene expression in DMBA-evoked mammary tumors and prolongs survival. FASEB J (2008) 0.80
Neuroprotective actions of perinatal choline nutrition. Clin Chem Lab Med (2013) 0.80
Surface expression and limited proteolysis of ADAM10 are increased by a dominant negative inhibitor of dynamin. BMC Cell Biol (2011) 0.80
Molecular diagnostic testing in breast cancer. Semin Oncol Nurs (2015) 0.78
Differential modulation of nerve growth factor receptor (p75) and cholinergic gene expression in purified p75-expressing and non-expressing basal forebrain neurons by BMP9. Brain Res (2008) 0.78
Defective immune function of primary effusion lymphoma cells is associated with distinct KSHV gene expression profiles. Leuk Lymphoma (2004) 0.78
Novel oxysterols activate the Hedgehog pathway and induce osteogenesis. Bioorg Med Chem Lett (2012) 0.78
Mitogen-activated protein kinase kinase negatively modulates ciliary neurotrophic factor-activated choline acetyltransferase gene expression. Eur J Biochem (2002) 0.77
F-spondin/spon1b expression patterns in developing and adult zebrafish. PLoS One (2012) 0.76
Prenatal choline deficiency does not enhance hippocampal vulnerability after kainic acid-induced seizures in adulthood. Brain Res (2011) 0.75
Genetic tests to identify risk for breast cancer. Semin Oncol Nurs (2015) 0.75
Correction: Perinatal Choline Supplementation Reduces Amyloidosis and Increases Choline Acetyltransferase Expression in the Hippocampus of the APPswePS1dE9 Alzheimer's Disease Model Mice. PLoS One (2017) 0.75
The advancement of human pluripotent stem cell-derived therapies into the clinic. Development (2015) 0.75
Osteogenic effects of a potent Src-over-Abl-selective kinase inhibitor in the mouse. J Pharmacol Exp Ther (2011) 0.75